Nova Patents
PL1968612T3

Dinucleotide prodrugs

Abstract

The present invention discloses compounds of formula (I): which exhibit antiviral properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of anti-HBV treatment. The invention also relates to methods of treating a HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Term

0.2 yearsto projected expiry

Projected expiry 13 December 2026, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

12 priority claims, no other members on record

This recordMember, by publication datePriority claim

Priority claims12

Priority claims
DocumentOfficeKindDate
75003605United States of AmericaP
75003605United States of AmericaP
80029406United States of AmericaP
80029406United States of AmericaP
63752006United States of AmericaA
63752006United States of AmericaA
637520–––
750036P–––
800294P–––
US20050750036P–––
US20060637520–––
US20060800294P–––